Otsuka Targets Apotex In Latest Suit Over Generic Abilify
Otsuka Pharmaceutical Co. Ltd. on Monday continued in its crusade to protect the patents underlying the drug Abilify, alleging in New Jersey federal court that Apotex Corp. is attempting to bring...To view the full article, register now.
Already a subscriber? Click here to view full article